Restricted Diffusion in Cerebral Toxoplasmosis Mimicking Primary Central Nervous System Lymphoma in Newly Diagnosed Advanced HIV: A Case Report

Cerebral toxoplasmosis is an important cause of intracranial mass lesions in patients with human immunodeficiency virus (HIV) infection and may be difficult to distinguish radiographically from primary central nervous system lymphoma (PCNSL). Although diffusion-weighted imaging may assist in the differential diagnosis, substantial overlap exists between these entities. We describe a 47-year-old man who presented with two weeks of progressive weakness beginning in the right lower extremity and subsequently progressing to profound bilateral lower-extremity weakness and generalized fatigue. Noncontrast computed tomography of the head demonstrated extensive vasogenic edema centered in the posterior left parietal lobe with compression of the left lateral ventricle and approximately 6 mm of midline shift. Magnetic resonance imaging (MRI) demonstrated multiple enhancing supratentorial lesions involving both cerebral hemispheres, including a dominant 3.9-cm left parietal lesion with extensive surrounding vasogenic edema and prominent restricted diffusion. Further evaluation revealed a new diagnosis of HIV with severe immunosuppression and a CD4 count of 26 cells/µL. Toxoplasma gondii serology demonstrated IgG greater than 400 IU/mL with negative IgM. Although cerebral toxoplasmosis was favored, PCNSL remained an important diagnostic consideration because of the marked diffusion restriction and absence of cerebrospinal fluid or tissue confirmation. Empiric trimethoprim-sulfamethoxazole therapy was initiated for a six-week course. Repeat MRI 15 days after initiation of therapy demonstrated interval reduction in the enhancing lesions, substantially decreased vasogenic edema, and improvement in associated mass effect, supporting a presumptive diagnosis of cerebral toxoplasmosis. This case highlights that prominent restricted diffusion does not exclude cerebral toxoplasmosis and emphasizes the importance of integrating immune status, lesion distribution, serologic findings, and response to empiric therapy when differentiating toxoplasmosis from PCNSL in patients with advanced HIV.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-16
DOI
https://doi.org/10.7759/cureus.119734
Primary Topic
Toxoplasma gondii Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Restricted Diffusion in Cerebral Toxoplasmosis Mimicking Primary Central Nervous System Lymphoma in Newly Diagnosed Advanced HIV: A Case Report

Lintu Ramachandran, Junaid Essa, Hanna Malik
Cureus
Toxoplasma gondii Research Studies
article

Restricted Diffusion in Cerebral Toxoplasmosis Mimicking Primary Central Nervous System Lymphoma in Newly Diagnosed Advanced HIV: A Case Report

Lintu Ramachandran, Junaid Essa, Hanna Malik
article en

Abstract

Cerebral toxoplasmosis is an important cause of intracranial mass lesions in patients with human immunodeficiency virus (HIV) infection and may be difficult to distinguish radiographically from primary central nervous system lymphoma (PCNSL). Although diffusion-weighted imaging may assist in the differential diagnosis, substantial overlap exists between these entities. We describe a 47-year-old man who presented with two weeks of progressive weakness beginning in the right lower extremity and subsequently progressing to profound bilateral lower-extremity weakness and generalized fatigue. Noncontrast computed tomography of the head demonstrated extensive vasogenic edema centered in the posterior left parietal lobe with compression of the left lateral ventricle and approximately 6 mm of midline shift. Magnetic resonance imaging (MRI) demonstrated multiple enhancing supratentorial lesions involving both cerebral hemispheres, including a dominant 3.9-cm left parietal lesion with extensive surrounding vasogenic edema and prominent restricted diffusion. Further evaluation revealed a new diagnosis of HIV with severe immunosuppression and a CD4 count of 26 cells/µL. Toxoplasma gondii serology demonstrated IgG greater than 400 IU/mL with negative IgM. Although cerebral toxoplasmosis was favored, PCNSL remained an important diagnostic consideration because of the marked diffusion restriction and absence of cerebrospinal fluid or tissue confirmation. Empiric trimethoprim-sulfamethoxazole therapy was initiated for a six-week course. Repeat MRI 15 days after initiation of therapy demonstrated interval reduction in the enhancing lesions, substantially decreased vasogenic edema, and improvement in associated mass effect, supporting a presumptive diagnosis of cerebral toxoplasmosis. This case highlights that prominent restricted diffusion does not exclude cerebral toxoplasmosis and emphasizes the importance of integrating immune status, lesion distribution, serologic findings, and response to empiric therapy when differentiating toxoplasmosis from PCNSL in patients with advanced HIV.

Cureus
University of Florida Health (US), University of Florida Health Science Center (US)
Good health and well-being
Toxoplasma gondii Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon